Provided By GlobeNewswire
Last update: Jul 8, 2024
NEW YORK and VIENNA, July 08, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that a 1-for-10 reverse stock split of its outstanding shares of common stock will be effective as of 5:00 p.m. Eastern Time on July 9, 2024.
NASDAQ:HOOK (6/20/2025, 8:00:02 PM)
1.29
-0.01 (-1.15%)
Find more stocks in the Stock Screener